{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:21:44Z","timestamp":1788873704766,"version":"build-2803163510"},"reference-count":109,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1080\/17512433.2026.2626458","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:01:06Z","timestamp":1770364866000},"page":"117-132","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["New and emerging treatments for vitiligo: a narrative review"],"prefix":"10.1080","volume":"19","author":[{"given":"Carolina Rodrigues","family":"Mendon\u00e7a","sequence":"first","affiliation":[{"name":"University of Porto","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Mohamed","sequence":"additional","affiliation":[{"name":"University of Toronto","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Mohamed","sequence":"additional","affiliation":[{"name":"McMaster University","place":["Hamilton, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Centro Hospitalar Universit\u00e1rio de Sto Ant\u00f3nio","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Torres","sequence":"additional","affiliation":[{"name":"University of Porto","place":["Porto, Portugal"]},{"name":"Centro Hospitalar Universit\u00e1rio de Sto Ant\u00f3nio","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60763-7"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.04.009"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417306"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI185785"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2021.09.008"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15743"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-100919-023531"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.986918"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-022-00752-6"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.10.048"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_310_18"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903357509"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.12.041"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0696"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13215"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsi.2016.05.005"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02121-x"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12991"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10229"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12749"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12121698"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107910"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12740"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12766"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_71_2024"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.4483"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12918"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14404"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-020-02108-8"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.24.038"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17157"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00447-y"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475420972340"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002581"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.25259\/IJDVL_15_2023"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1735615"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14770"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2023.12.008"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02027-2"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-00892-5"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119889"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.02.049"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.023"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30609-7"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.165"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.404"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118828"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2025.2540014"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01928-y"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.11.005"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae266.027"},{"key":"e_1_3_4_54_1","unstructured":"A 104-week study of ritlecitinib oral capsules in adults with nonsegmental vitiligo (active and stable) Tranquillo 2. Tranquillo 2: National Library of Medicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT06072183"},{"key":"e_1_3_4_55_1","unstructured":"A 52-week study to learn about the safety and effects of ritlecitinib in participants with nonsegmental vitiligo. Tranquillo LTE: National Library of Medicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT06163326"},{"key":"e_1_3_4_56_1","unstructured":"A 52-week study of ritlecitinib oral capsules in adults and adolescents with nonsegmental vitiligo (active and stable). Tranquillo: National Library of Medicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT05583526"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S356316"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0723-3"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/15593258221105370"},{"key":"e_1_3_4_60_1","unstructured":"Evaluation of effect and tolerance of the Association of baricitinib and phototherapy versus phototherapy in adults with progressive vitiligo. BARVIT: National Library of Medicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT04822584"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2024.01.033"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01211-z"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102655"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-03658-x"},{"key":"e_1_3_4_65_1","unstructured":"A study to assess adverse events and effectiveness of upadacitinib oral tablets in adult and adolescent participants with vitiligo. Viti-Up: National Library of Medicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT06118411"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2019.08.032"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.13290"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15821"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.04.032"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2018.042"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18606"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.IDOJ_474_18"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.3390\/life14091127"},{"key":"e_1_3_4_74_1","unstructured":"Safety and tolerability study of Cerdulatinib gel 0.37% in adults with. Vitiligo: National Library of Medicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT04103060"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0501-5"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.1875"},{"key":"e_1_3_4_77_1","unstructured":"A study to compare the efficacy and safety of SCENESSE and Narrow-band ultraviolet (NB-UVB) light versus NB-UVB light alone in patients with. Vitiligo: National Library of Medicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT06109649"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16468"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13175"},{"key":"e_1_3_4_80_1","unstructured":"Latanoprost plus NB-UVB versus each alone in non-segmental vitiligo: clinical and laboratory Evaluation. National Library of Medicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT04811326"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13648"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15198"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-023-02700-8"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.01.001"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2386234"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-024-00668-0"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.12.073"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.11.031"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12923"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37180"},{"key":"e_1_3_4_91_1","unstructured":"Study of Efficacy. Safety and tolerability of Crisaborole and PF-07038124 with and without NBUVB in vitiligo. National Library of Mdicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT05298033"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111429"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12194"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.12929"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13103"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221119646"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000003503"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-020-03195-9"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13908"},{"key":"e_1_3_4_100_1","unstructured":"A trial to test the safety and efficacy of TEV-53408 in treating. Vitiligo: National Library of Medicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT06625177"},{"key":"e_1_3_4_101_1","unstructured":"Evaluation of AMG 714 for vitiligo. REVEAL: National Library of Medicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT04338581"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.08.018"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12789"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01476-3"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12392"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.169136"},{"key":"e_1_3_4_107_1","unstructured":"Pilot study assessing the effect of tildrakizumab in vitiligo (TILDVIT-1227). National Library of Medicine; Available from: https:\/\/clinicaltrials.gov\/study\/NCT04971200"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13346"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.70113"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14436"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2025.2483808"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2026.2626458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:42:50Z","timestamp":1772721770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2026.2626458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1080\/17512433.2026.2626458"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2026.2626458","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}